Ring Therapeutics Raises $86.5M in Series C Funding to Create Next Generation Programmable Medicines
Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation...
Ring Therapeutics Raises $86.5M in Series C Funding to Create Next Generation Programmable Medicines
Aera Therapeutics Launches with $193 M for the Next Generation of Transformative Genetic Medicines
Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin
DNA Writing Goes Enzymatic, Encourages Pursuit of Bold Visions
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
Federation Bio Administers First Dose in Phase 1 Clinical Trial
Escient Pharmaceuticals Announces $120 Million Series C Financing
Indigo Expands 2023 Biological Crop Protection Line with New Biofungicide